Jabra Enhance Pro 20 at Costco vs Lexie B3

The Jabra Enhance Pro 20 at Costco is a behind-the-ear prescription hearing aid priced at $1,600, placing it in the premium tier. With a SoundScore of 4.0/5 and an A grade, it ranks #25 of 39 prescription hearing aids tested in our lab. In our testing, this device demonstrates notable strengths in own-voice comfort, scoring 3.5/5—0.80 points above the category average. This solid performance means wearers may find their own voice sounds more natural compared to many competitors. Feedback handling is excellent at 4.8/5, slightly above the category average, indicating reliable stability during movement and phone use. However, the Enhance Pro 20 shows limitations in challenging listening environments. Speech-in-noise performance scores just 1.1/5, falling 0.97 points below the category average—a significant gap that may affect conversations in restaurants, social gatherings, or other noisy settings. Speech-in-quiet is solid at 3.2/5 in absolute terms, though still 0.17 points below the category average. Music streaming scores 2.8/5, which is above the category average but only mixed in absolute terms. This device suits users who prioritize comfortable own-voice perception and excellent feedback control, and who spend most listening time in quieter environments. Those frequently navigating noisy situations may want to consider alternatives like the Rexton Reach R-Li T80 at Costco, which scored 4.56/5 in our testing. The Enhance Pro 20 includes rechargeable batteries, iPhone and Android streaming, and hands-free functionality.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.